Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-28Clinical Trial Update: Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer [Phase 3]
Phase 3 trial evaluating pembrolizumab (MK-3475) as adjuvant therapy for triple-negative breast cancer; currently active-not-recruiting.
-
CLINICAL_TRIALS trial_result · 2026-08-20Clinical Trial Results: Quantitative Transmission Imaging Compared With MRI as Supplemental Screening for High Lifetime Risk of Breast Cancer [NA]
A completed clinical trial comparing quantitative transmission imaging with MRI as a supplemental screening method for individuals at high l…
-
CLINICAL_TRIALS trial_result · 2026-08-19Clinical Trial Results: Volumetric Specimen Imager Device for the Intraoperative Imaging of Patients With Breast Carcinoma and Breast Ductal Carcinoma In Situ, The VIVID Study [Phase 2]
Phase 2 clinical trial evaluating a volumetric specimen imager for intraoperative imaging in breast cancer and ductal carcinoma in situ; res…
-
CLINICAL_TRIALS trial_result · 2026-08-18Clinical Trial Results: Michigan Genetic Hereditary Testing (MiGHT) [NA]
Results from the MiGHT genetic hereditary testing trial conducted at University of Michigan Rogel Cancer Center in breast, colorectal, and o…
-
CLINICAL_TRIALS trial_result · 2026-08-13Clinical Trial Results: Evaluating Digital Micro-Interventions to Reduce Distress and Increase Wellbeing in Breast Cancer Survivors [NA]
Completed clinical trial evaluating digital micro-interventions to reduce distress and improve wellbeing in breast cancer survivors.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-08-12Clinical Trial Results: Double-blind Randomized Controlled Trial Comparing Suvorexant 20 mg to Placebo for Treatment of Insomnia in Cancer Survivors [Phase 4]
Phase 4 double-blind RCT comparing suvorexant 20 mg to placebo for insomnia in cancer survivors (breast cancer).
-
CLINICAL_TRIALS trial_result · 2026-08-07Clinical Trial Results: Evaluating Smoking Cessation Protocols in Cancer Patients: NRT, MI, CBT or Hypnotherapy [NA]
Clinical trial evaluating smoking cessation protocols in cancer patients has terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2026-08-07Clinical Trial Results: Endocrine Response in Women With Invasive Lobular Breast Cancer [Phase 2]
Phase 2 trial results on endocrine response in women with invasive lobular breast cancer.
-
CLINICAL_TRIALS trial_result · 2026-08-06Clinical Trial Results: Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer [Phase 3]
Phase 3 trial comparing docetaxel and cyclophosphamide to anthracycline-based chemotherapy in HER2-negative breast cancer completed with pos…
-
CLINICAL_TRIALS trial_result · 2026-08-03Clinical Trial Results: Understanding and Addressing Rejection of Personalized Breast Cancer Risk Information: Administrative Supplement Study [Phase 2]
Phase 2 administrative supplement study investigating rejection of personalized breast cancer risk information.
-
CLINICAL_TRIALS trial_result · 2026-07-30Clinical Trial Update: Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer [Phase 3]
Phase 3 trial evaluating pembrolizumab as adjuvant therapy for triple-negative breast cancer is active/not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-07-30Clinical Trial Results: Study of iBreast, a Handheld Device to Detect Breast Abnormalities During Screening Visits for Breast Cancer [NA]
Results from a completed study evaluating iBreast, a handheld device for detecting breast abnormalities during screening visits for breast c…
-
CLINICAL_TRIALS trial_result · 2026-07-28Clinical Trial Results: A Study to Allow Continued Dosing and/or Follow-up of Patients Who Have Had Previous Exposure to Poziotinib [Phase 2]
Phase 2 trial evaluating continued dosing/follow-up for patients previously exposed to poziotinib; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2026-07-24Clinical Trial Results: Gemcitabine, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer After Prior Trastuzumab/Pertuzumab, or Pertuzumab Based Therapy [Phase 2]
Phase 2 trial evaluating gemcitabine, trastuzumab, and pertuzumab in metastatic HER2-positive breast cancer after prior anti-HER2 therapy; r…
-
CLINICAL_TRIALS trial_result · 2026-07-21Clinical Trial Results: Pilot Study of Cabazitaxel and Paclitaxel in HER2 Negative Breast Cancer [Phase 2]
Phase 2 pilot study investigating cabazitaxel and paclitaxel in HER2-negative metastatic breast cancer completed.
-
CLINICAL_TRIALS trial_result · 2026-07-21Clinical Trial Results: Study of Elacestrant in Combination With Onapristone in Patients With Advanced or Metastatic Breast Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating elacestrant in combination with onapristone in advanced or metastatic breast cancer; study terminated with result…
-
CLINICAL_TRIALS trial_result · 2026-07-21Clinical Trial Update: Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer [Phase 3]
Phase 3 clinical trial evaluating pembrolizumab (MK-3475) as adjuvant therapy for triple-negative breast cancer; status ACTIVE_NOT_RECRUITIN…
-
CLINICAL_TRIALS trial_result · 2026-07-17Clinical Trial Results: Sulindac and Breast Density in Women at Risk of Developing Breast Cancer [Phase 2]
Phase 2 clinical trial results evaluating sulindac in women at risk of developing breast cancer, focusing on breast density outcomes.
-
CLINICAL_TRIALS trial_result · 2026-07-16Clinical Trial Results: A Phase I, Single-arm, Open-label, Dose-escalation Study to Evaluate the Safety and Tolerability of Orialpha (BD-C) in Healthy Adult Volunteers [Phase 1]
Phase I, single-arm dose-escalation study evaluating safety and tolerability of Orialpha (BD-C) in healthy adult volunteers; completed with …
-
CLINICAL_TRIALS trial_result · 2026-07-15Clinical Trial Results: A Study to Learn About the Study Medicine PF-07220060 Together With Letrozole Compared to Letrozole Alone in Women Post Menopause [Phase 2]
Phase 2 trial evaluating PF-07220060 with letrozole versus letrozole alone in postmenopausal women with breast cancer; results completed wit…
-
CLINICAL_TRIALS trial_result · 2026-07-13Clinical Trial Results: Wide Field OCT + AI for Positive Margin Rates in Breast Conservation Surgery. [NA]
A completed clinical trial evaluating wide field optical coherence tomography with AI to reduce positive margin rates during breast-conservi…
-
CLINICAL_TRIALS trial_result · 2026-07-10Clinical Trial Results: Study of the Molecular Features of Postmenopausal Women With HR+ HER2-negative aBC on First-line Treatment With Ribociclib and Letrozole and, in Patients With a PIK3CA Mutation, on Second-line Treatment With Alpelisib Plus Fulvestrant [Phase 3]
Phase 3 trial evaluating ribociclib + letrozole as first-line in HR+ HER2-negative advanced breast cancer, with alpelisib + fulvestrant as s…
-
CLINICAL_TRIALS trial_result · 2026-07-10Clinical Trial Results: Reducing Metabolic Dysregulation in Obese Latina Breast Cancer Survivors Using Physical Activity [NA]
A completed clinical trial investigating whether physical activity reduces metabolic dysregulation in obese Latina breast cancer survivors.
-
CLINICAL_TRIALS trial_result · 2026-07-09Clinical Trial Results: A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study of pegylated IL-10 (pegilodecakin) in adults with advanced solid tumors; results from a first-in-human trial assessing safety …
-
CLINICAL_TRIALS trial_result · 2026-07-08Clinical Trial Results: Efficacy and Safety of Ribociclib in Pre- and Postmenopausal Chinese Women With HR Positive, HER2-negative, Advanced Breast Cancer. [Phase 2]
Phase 2 trial evaluating ribociclib for efficacy and safety in pre- and postmenopausal Chinese women with HR-positive, HER2-negative advance…